Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine sedation for acute traumatic brain injury in ICU
ACTRN12623000594628Phase 2Recruiting
- Sponsor
- Monash University
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, open-label trial of ketamine in traumatic brain injury (TBI) (2 arms), sponsored by Monash University. Primary endpoint: Total cumulative dose of intravenous ketamine administered. Started Aug 2023; status: recruiting.
02
Drugs
ketamine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ACTRN12623000594628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000594628.